Search Results | Diabetes | American Diabetes Association

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Erratum. TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model. Diabetes 2011;60:2963–2974

Yun Ti, Guo-lu Xie, Zhi-hao Wang, Xiao-lei Bi, Wen-yuan Ding, Jia Wang, Gui-hua Jiang, Pei-li Bu, Yun Zhang, Ming Zhong, Wei Zhang

Diabetes 2023;72(6):820

DOI: https://doi.org/10.2337/db23-er06a

Published: 18 April 2023

View article titled, Erratum. TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model. Diabetes 2011;60:2963–2974

Meeting Abstracts

355-OR: WATCH-DM Identifies Diabetic Cardiomyopathy: A Multicohort Analysis

MATTHEW W. SEGAR, KERSHAW PATEL, MUTHIAH VADUGANATHAN, ALVIN CHANDRA, DUWAYNE L. WILLETT, AMBARISH PANDEY

Diabetes 2022;71(Supplement_1):355-OR

DOI: https://doi.org/10.2337/db22-355-OR

Published: 01 June 2022

View article titled, 355-OR: WATCH-DM Identifies Diabetic Cardiomyopathy: A Multicohort Analysis

Meeting Abstracts

207-LB: Aldose Reductase Inhibition by AT-001 Limits Diastolic Dysfunction and Adverse Remodelling in Diabetic Cardiomyopathy

QUTUBA G. KARWI, KESHAV GOPAL, SEYED AMIRHOSSEIN TABATABAEI DAKHILI, CORY S. WAGG, LIYAN ZHANG, QIUYU SUN, CHRISTINA T. SAED, SAI PANIDARAPU, RICCARDO PERFETTI, RAVICHANDRAN RAMASAMY, JOHN R. USSHER, GARY LOPASCHUK

Diabetes 2022;71(Supplement_1):207-LB

DOI: https://doi.org/10.2337/db22-207-LB

Published: 01 June 2022

View article titled, 207-LB: Aldose Reductase Inhibition by AT-001 Limits Diastolic Dysfunction and Adverse Remodelling in Diabetic Cardiomyopathy

Meeting Abstracts

1090-P: Prevalence of Diabetic Cardiomyopathy in an Electronic Health Record–Based Cohort

MATTHEW W. SEGAR, KERSHAW PATEL, MUTHIAH VADUGANATHAN, ALVIN CHANDRA, DUWAYNE L. WILLETT, AMBARISH PANDEY

Diabetes 2022;71(Supplement_1):1090-P

DOI: https://doi.org/10.2337/db22-1090-P

Published: 01 June 2022

View article titled, 1090-P: Prevalence of Diabetic Cardiomyopathy in an Electronic Health Record–Based Cohort

Meeting Abstracts

971-P: Prevalence of Diabetic Cardiomyopathy in Real-World Practice: A Longitudinal Cohort Study

IWONA SWIATKIEWICZ, NEEJA T. PATEL, PAM R. TAUB

Diabetes 2021;70(Supplement_1):971-P

DOI: https://doi.org/10.2337/db21-971-P

Published: 01 June 2021

View article titled, 971-P: Prevalence of Diabetic Cardiomyopathy in Real-World Practice: A Longitudinal Cohort Study

Meeting Abstracts

978-P: Prevalence of Diabetic Cardiomyopathy in Adults with Diabetes or Prediabetes and Its Association with the Risk of Overt Heart Failure: A Multicohort Analysis

MATTHEW W. SEGAR, KERSHAW PATEL, NITIN KONDAMUDI, AMBARISH PANDEY

Diabetes 2021;70(Supplement_1):978-P

DOI: https://doi.org/10.2337/db21-978-P

Published: 01 June 2021

View article titled, 978-P: Prevalence of Diabetic Cardiomyopathy in Adults with Diabetes or Prediabetes and Its Association with the Risk of Overt Heart Failure: A Multicohort Analysis

Meeting Abstracts

362-P: Punicalagin Promotes Mitochondrial Fusion and Alleviates Diabetic Cardiomyopathy via Regulating PTP1B-Stat3-Opa1 Pathway

MINGGE DING, MAN LI, FENG FU, CHAOYANG LIU

Diabetes 2021;70(Supplement_1):362-P

DOI: https://doi.org/10.2337/db21-362-P

Published: 01 June 2021

View article titled, 362-P: Punicalagin Promotes Mitochondrial Fusion and Alleviates Diabetic Cardiomyopathy via Regulating PTP1B-Stat3-Opa1 Pathway

Meeting Abstracts

379-P: Aldose Reductase Inhibition by AT-001 Prevents Diabetic Cardiomyopathy via Reducing Myocardial Fatty Acid Oxidation Rates

KESHAV GOPAL, QUTUBA G. KARWI, SEYED AMIRHOSSEIN TABATABAEI DAKHILI, CORY S. WAGG, RICCARDO PERFETTI, RAVICHANDRAN RAMASAMY, JOHN R. USSHER, GARY LOPASCHUK

Diabetes 2021;70(Supplement_1):379-P

DOI: https://doi.org/10.2337/db21-379-P

Published: 01 June 2021

View article titled, 379-P: Aldose Reductase Inhibition by AT-001 Prevents Diabetic Cardiomyopathy via Reducing Myocardial Fatty Acid Oxidation Rates

Meeting Abstracts

1043-P: Diabetic Cardiomyopathy: A Systematic Analysis of Epidemiological Studies

RICCARDO PERFETTI, SHOSHANA SHENDELMAN

Diabetes 2021;70(Supplement_1):1043-P

DOI: https://doi.org/10.2337/db21-1043-P

Published: 01 June 2021

View article titled, 1043-P: Diabetic Cardiomyopathy: A Systematic Analysis of Epidemiological Studies

Journal Articles

Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice

Huimei Zang, Weiwei Wu, Lei Qi, Wenbin Tan, Prakash Nagarkatti, Mitzi Nagarkatti, Xuejun Wang, Taixing Cui

Diabetes 2020;69(12):2720–2734

DOI: https://doi.org/10.2337/db19-1176

Published: 18 September 2020

View article titled, Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice

Meeting Abstracts

458-P: Resveratrol Attenuates Diabetic Cardiomyopathy by Inhibiting Asymmetric Dimethylarginine-Induced PGC-1a Acetylation

YAN XIONG, WEI-JIN FANG, ZHI-MIN HE

Diabetes 2020;69(Supplement_1):458-P

DOI: https://doi.org/10.2337/db20-458-P

Published: 01 June 2020

View article titled, 458-P: Resveratrol Attenuates Diabetic Cardiomyopathy by Inhibiting Asymmetric Dimethylarginine-Induced PGC-1a Acetylation

Meeting Abstracts

442-P: Comparative Study of the Effects of GLP-1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms

ELSAYED A. EID, ABDELAZIZ HUSSEIN, LASHIN LASHIN, MEDHAT TAHA

Diabetes 2020;69(Supplement_1):442-P

DOI: https://doi.org/10.2337/db20-442-P

Published: 01 June 2020

View article titled, 442-P: Comparative Study of the Effects of GLP-1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms

Meeting Abstracts

409-P: Engineered Cardiac Tissues: A Novel In Vitro Model to Investigate the Pathophysiology of Diabetic Cardiomyopathy

XIANG WANG, YANG ZHENG, BRADLEY B. KELLER, LU CAI

Diabetes 2020;69(Supplement_1):409-P

DOI: https://doi.org/10.2337/db20-409-P

Published: 01 June 2020

View article titled, 409-P: Engineered Cardiac Tissues: A Novel In Vitro Model to Investigate the Pathophysiology of Diabetic Cardiomyopathy

Meeting Abstracts

451-P: Proteome Profiling in Rat Cardiomyoblasts: Understanding Diabetic Cardiomyopathy

BERND STRATMANN, BRITTA EGGERS, YVONNE MATTERN, KATRIN MARCUS, DIETHELM TSCHOEPE

Diabetes 2020;69(Supplement_1):451-P

DOI: https://doi.org/10.2337/db20-451-P

Published: 01 June 2020

View article titled, 451-P: Proteome Profiling in Rat Cardiomyoblasts: Understanding Diabetic Cardiomyopathy

Meeting Abstracts

186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

RICCARDO PERFETTI, FRANCESCA C. LAWSON, JULIO ROSENSTOCK, JAMES JANUZZI, JR., SHOSHANA SHENDELMAN, STELLA WANG, AMEEN F. GHANNAM

Diabetes 2020;69(Supplement_1):186-OR

DOI: https://doi.org/10.2337/db20-186-OR

Published: 01 June 2020

View article titled, 186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

Meeting Abstracts

1824-P: Activation of Cardiac Mitochondrial Akt1 Improved Diabetic Cardiomyopathy through Inhibition of Melatonin Degradation and Remotely Improved Liver Metabolism

ALBERT TA, YU-HAN CHEN, YUMAY CHEN, HUGO Y.H. LIN, PING H. WANG

Diabetes 2020;69(Supplement_1):1824-P

DOI: https://doi.org/10.2337/db20-1824-P

Published: 01 June 2020

View article titled, 1824-P: Activation of Cardiac Mitochondrial Akt1 Improved Diabetic Cardiomyopathy through Inhibition of Melatonin Degradation and Remotely Improved Liver Metabolism

Meeting Abstracts

2137-PUB: Exercise and Stevia R. Extracts Attenuate Diabetic Cardiomyopathy in Type 2 Diabetic Rats via Upregulation of Nrf2 and Suppression of Oxidative Stress, Fibrosis, Apoptosis, and Sympathetic Overactivity

ABDELAZIZ HUSSEIN, ELSAYED A. EID, MEDHAT TAHA, LASHIN LASHIN

Diabetes 2020;69(Supplement_1):2137-PUB

DOI: https://doi.org/10.2337/db20-2137-PUB

Published: 01 June 2020

View article titled, 2137-PUB: Exercise and Stevia R. Extracts Attenuate Diabetic Cardiomyopathy in Type 2 Diabetic Rats via Upregulation of Nrf2 and Suppression of Oxidative Stress, Fibrosis, Apoptosis, and Sympathetic Overactivity

Meeting Abstracts

1080-P: Addressing the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy, a Potent and Selective Next Generation Aldose Reductase Inhibitor

RICCARDO PERFETTI, GAUTHAM YEPURI, NOSIRUDEEN A. QUADRI, AMEEN F. GHANNAM, RAVICHANDRAN RAMASAMY, SHOSHANA SHENDELMAN

Diabetes 2020;69(Supplement_1):1080-P

DOI: https://doi.org/10.2337/db20-1080-P

Published: 01 June 2020

View article titled, 1080-P: Addressing the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy, a Potent and Selective Next Generation Aldose Reductase Inhibitor

Journal Articles

Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction

Adam R. Wende, John C. Schell, Chae-Myeong Ha, Mark E. Pepin, Oleh Khalimonchuk, Hansjörg Schwertz, Renata O. Pereira, Manoja K. Brahma, Joseph Tuinei, Ariel Contreras-Ferrat, Li Wang, Chase A. Andrizzi, Curtis D. Olsen, Wayne E. Bradley, Louis J. Dell’Italia, Wolfgang H. Dillmann, Sheldon E. Litwin, E. Dale Abel

Diabetes 2020;69(10):2094–2111

DOI: https://doi.org/10.2337/db19-1057

Published: 04 May 2020

View article titled, Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction

Journal Articles

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Xin Tan, Lizhi Hu, Zhiping Shu, Long Chen, Xiangrao Li, Meng Du, Dan Sun, Xiaoxiang Mao, Shan Deng, Kai Huang, Fengxiao Zhang

Diabetes 2019;68(11):2063–2073

DOI: https://doi.org/10.2337/db18-1231

Published: 22 August 2019

View article titled, Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Includes: Supplementary data

NARROW

Erratum. TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model. Diabetes 2011;60:2963–2974

355-OR: WATCH-DM Identifies Diabetic Cardiomyopathy: A Multicohort Analysis

207-LB: Aldose Reductase Inhibition by AT-001 Limits Diastolic Dysfunction and Adverse Remodelling in Diabetic Cardiomyopathy

1090-P: Prevalence of Diabetic Cardiomyopathy in an Electronic Health Record–Based Cohort

971-P: Prevalence of Diabetic Cardiomyopathy in Real-World Practice: A Longitudinal Cohort Study

978-P: Prevalence of Diabetic Cardiomyopathy in Adults with Diabetes or Prediabetes and Its Association with the Risk of Overt Heart Failure: A Multicohort Analysis

362-P: Punicalagin Promotes Mitochondrial Fusion and Alleviates Diabetic Cardiomyopathy via Regulating PTP1B-Stat3-Opa1 Pathway

379-P: Aldose Reductase Inhibition by AT-001 Prevents Diabetic Cardiomyopathy via Reducing Myocardial Fatty Acid Oxidation Rates

1043-P: Diabetic Cardiomyopathy: A Systematic Analysis of Epidemiological Studies

Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice

458-P: Resveratrol Attenuates Diabetic Cardiomyopathy by Inhibiting Asymmetric Dimethylarginine-Induced PGC-1a Acetylation

442-P: Comparative Study of the Effects of GLP-1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms

409-P: Engineered Cardiac Tissues: A Novel In Vitro Model to Investigate the Pathophysiology of Diabetic Cardiomyopathy

451-P: Proteome Profiling in Rat Cardiomyoblasts: Understanding Diabetic Cardiomyopathy

186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

1824-P: Activation of Cardiac Mitochondrial Akt1 Improved Diabetic Cardiomyopathy through Inhibition of Melatonin Degradation and Remotely Improved Liver Metabolism

2137-PUB: Exercise and Stevia R. Extracts Attenuate Diabetic Cardiomyopathy in Type 2 Diabetic Rats via Upregulation of Nrf2 and Suppression of Oxidative Stress, Fibrosis, Apoptosis, and Sympathetic Overactivity

1080-P: Addressing the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy, a Potent and Selective Next Generation Aldose Reductase Inhibitor

Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only